fancode is free or not A number of pharmaceutical companies are turning to the grassroots market Mavacamten, an innovative drug for hypertrophic cardiomyopathy, succeeds in Phase III clinical trial ...

AFICAMTEN was found to be a safe and effective treatment for symptomatic nonobstructive hypertrophic cardiomyopathy (nHCM), ...

A study found that SGLT2 inhibitors, a hypoglycemic agent, are effective in 'hypertensive cardiomyopathy', a disease in which ...

The following is a summary of “Detection of late gadolinium enhancement in patients with hypertrophic cardiomyopathy using ...

The following is a summary of “Effect of disopyramide therapy on functional capacity improvement in patients with obstructive ...

Meredith Everhart and her sister Abbey Cannon, who are 7 years apart, both had heart transplants at age 38. This Christmas, ...

OLX-101A is under clinical development by OliX Pharmaceuticals and currently in Phase II for Hypertrophic Scars. According to GlobalData, Phase II drugs for Hypertrophic Scars does not have sufficient ...

The cardiac myosin inhibitor, under priority review for obstructive and non-obstructive hypertrophic cardiomyopathy, was ...

Cytokinetics (NASDAQ:CYTK) said EU regulators have validated the market application for its drug aficamten for the treatment ...

A study has found that there are similar safety profiles for -blockers and verapamil in patients with low-risk hypertrophic ...

Cytokinetics (CYTK) announced that the European Medicines Agency, EMA, has validated the Marketing Authorization Application, MAA, for ...

Rohan Mirchandani, the 42-year-old co-founder of Epigamia yogurt, tragically died from cardiac arrest. His company, Drums ...